Latest news
HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 11:14:59 GMTOverfeeding cancer to stunt its growth - Drug Discovery NewsDrug Discovery News · Thu, 06 Aug 2026 13:46:00 GMTExperimental Drug Turns Cancer’s Favorite Fuel — Sugar — Against It - UT Austin NewsUT Austin News · Wed, 05 Aug 2026 21:42:35 GMTFDA-Approved ADCs Prompt the Need for Revisions to the Breast Cancer Management Road Map - OncLiveOncLive · Wed, 05 Aug 2026 20:23:21 GMTWhat FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates - Chromatography OnlineChromatography Online · Wed, 05 Aug 2026 17:24:33 GMTLinkers, Payloads, and Peptide Considerations in Antibody Drug Conjugate Chemistry - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 17:02:20 GMTFraming the Evolving Bioconjugate Landscape - Chromatography OnlineChromatography Online · Wed, 05 Aug 2026 16:06:49 GMTMeet the Panelists for the Next-Generation Bioconjugation Panel - Chromatography OnlineChromatography Online · Wed, 05 Aug 2026 15:41:45 GMT